Gerald R. Ewoldt

Array ( [id] => 6658809 [patent_doc_number] => 20030078499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Microporation of tissue for delivery of bioactive agents' [patent_app_type] => new [patent_app_number] => 10/272292 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 40877 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078499.pdf [firstpage_image] =>[orig_patent_app_number] => 10272292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634039 [patent_doc_number] => 08012487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Synthetic peptides and DNA sequences for treatment of multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 10/492794 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 15231 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012487.pdf [firstpage_image] =>[orig_patent_app_number] => 10492794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7133511 [patent_doc_number] => 20040043022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Treating t-cell mediated diseases by modulating dr6 activity' [patent_app_type] => new [patent_app_number] => 10/257907 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 29778 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043022.pdf [firstpage_image] =>[orig_patent_app_number] => 10257907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6842539 [patent_doc_number] => 20030147886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Novel antibody compositions for preparing enriched dendritic cell preparations' [patent_app_type] => new [patent_app_number] => 10/265622 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16353 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20030147886.pdf [firstpage_image] =>[orig_patent_app_number] => 10265622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1088998 [patent_doc_number] => 06828150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-07 [patent_title] => 'Antigen presenting system and methods for activation of T-cells' [patent_app_type] => B2 [patent_app_number] => 10/266463 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 48 [patent_no_of_words] => 36637 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828150.pdf [firstpage_image] =>[orig_patent_app_number] => 10266463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 852708 [patent_doc_number] => 07378089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Gene therapy for the prevention of autoimmune disease' [patent_app_type] => utility [patent_app_number] => 10/263937 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5659 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378089.pdf [firstpage_image] =>[orig_patent_app_number] => 10263937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 869019 [patent_doc_number] => 07365155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Immunoregulator' [patent_app_type] => utility [patent_app_number] => 10/262522 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 23975 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365155.pdf [firstpage_image] =>[orig_patent_app_number] => 10262522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7336701 [patent_doc_number] => 20040132644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Composition and method for treating diabetes' [patent_app_type] => new [patent_app_number] => 10/253733 [patent_app_country] => US [patent_app_date] => 2002-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4899 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132644.pdf [firstpage_image] =>[orig_patent_app_number] => 10253733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 520253 [patent_doc_number] => 07189826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-13 [patent_title] => 'Monoclonal human natural antibodies' [patent_app_type] => utility [patent_app_number] => 10/251526 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 12639 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189826.pdf [firstpage_image] =>[orig_patent_app_number] => 10251526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 642224 [patent_doc_number] => 07122638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-17 [patent_title] => 'Monoclonal human natural antibodies' [patent_app_type] => utility [patent_app_number] => 10/247946 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 12650 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122638.pdf [firstpage_image] =>[orig_patent_app_number] => 10247946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534785 [patent_doc_number] => 07872098 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-01-18 [patent_title] => 'Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies' [patent_app_type] => utility [patent_app_number] => 10/489967 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 5602 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872098.pdf [firstpage_image] =>[orig_patent_app_number] => 10489967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720342 [patent_doc_number] => 20060073116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Identification and use of high efficacy vaccine antigens which modulate antigen presenting cells' [patent_app_type] => utility [patent_app_number] => 10/246086 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14069 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073116.pdf [firstpage_image] =>[orig_patent_app_number] => 10246086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 887192 [patent_doc_number] => 07348005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-25 [patent_title] => 'Oral tolerance induction by collagen to prevent allograft rejection' [patent_app_type] => utility [patent_app_number] => 10/243797 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 43 [patent_no_of_words] => 39207 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/348/07348005.pdf [firstpage_image] =>[orig_patent_app_number] => 10243797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6855665 [patent_doc_number] => 20030129166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Human circulating dendritic cell compositions and methods' [patent_app_type] => new [patent_app_number] => 10/238986 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8816 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129166.pdf [firstpage_image] =>[orig_patent_app_number] => 10238986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6744614 [patent_doc_number] => 20030021797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Localization of major peptide autoepitopes for nucleosome specific T cells of systemic lupus erythematosus' [patent_app_type] => new [patent_app_number] => 10/211069 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 30792 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20030021797.pdf [firstpage_image] =>[orig_patent_app_number] => 10211069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518845 [patent_doc_number] => 20020192192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Antigen presenting cells, a process for preparing the same and their use as cellular vaccines' [patent_app_type] => new [patent_app_number] => 10/195065 [patent_app_country] => US [patent_app_date] => 2002-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6786 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192192.pdf [firstpage_image] =>[orig_patent_app_number] => 10195065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721329 [patent_doc_number] => 20030055019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity' [patent_app_type] => new [patent_app_number] => 10/196703 [patent_app_country] => US [patent_app_date] => 2002-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19948 [patent_no_of_claims] => 110 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055019.pdf [firstpage_image] =>[orig_patent_app_number] => 10196703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843035 [patent_doc_number] => 20030148382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'PanCAM nucleic acids and polypeptides' [patent_app_type] => new [patent_app_number] => 10/180410 [patent_app_country] => US [patent_app_date] => 2002-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 46697 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148382.pdf [firstpage_image] =>[orig_patent_app_number] => 10180410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774155 [patent_doc_number] => 20030017493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Methods for the detection and treatment of chronic immune diseases' [patent_app_type] => new [patent_app_number] => 10/174512 [patent_app_country] => US [patent_app_date] => 2002-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12732 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017493.pdf [firstpage_image] =>[orig_patent_app_number] => 10174512 [rel_patent_id] =>[rel_patent_doc_number] =>)